IHS(IHS)
IHS
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $1.80B | $1.85B | $1.98B | $2.17B | $2.33B |
| Low | $1.72B | $1.77B | $1.82B | $2.07B | $2.22B |
| High | $1.89B | $1.94B | $2.12B | $2.28B | $2.44B |
| EBITDA Avg | $161M | $166M | $177M | $194M | $208M |
| Low | $154M | $158M | $163M | $185M | $199M |
| High | $169M | $174M | $189M | $204M | $218M |
| EBIT Avg | $-249M | $-257M | $-274M | $-301M | $-322M |
| Low | $-261M | $-269M | $-293M | $-315M | $-338M |
| High | $-238M | $-245M | $-252M | $-286M | $-307M |
| Net Income Avg | $309M | $314M | $371M | $287M | $335M |
| Low | $290M | $295M | $240M | $269M | $314M |
| High | $329M | $334M | $501M | $305M | $356M |
| EPS Avg | $0.91 | $0.92 | $1.08 | $0.84 | $0.98 |
| Low | $0.85 | $0.86 | $0.70 | $0.79 | $0.92 |
| High | $0.96 | $0.98 | $1.47 | $0.89 | $1.04 |
| Analysts (Rev / EPS) | 2 / 1 | 3 / 1 | 3 / 2 | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $461M | $480M | $502M |
| Low | $461M | $480M | $502M |
| High | $461M | $480M | $502M |
| EBITDA Avg | $41M | $43M | $45M |
| Low | $41M | $43M | $45M |
| High | $41M | $43M | $45M |
| EBIT Avg | $-64M | $-66M | $-69M |
| Low | $-64M | $-66M | $-69M |
| High | $-64M | $-66M | $-69M |
| Net Income Avg | $113M | $144M | $100M |
| Low | $113M | $144M | $100M |
| High | $113M | $144M | $100M |
| EPS Avg | $0.33 | $0.42 | $0.29 |
| Low | $0.33 | $0.42 | $0.29 |
| High | $0.33 | $0.42 | $0.29 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |